RE:RE:RE:Response from FredBsmart, I have talk to Fred last week about the the program between FDA and DoD and I had the same answer as Stockman.
This is not a forgery or a lie.
Fred would not say that Prometic is already in contact with the DoD about the use of Ryplazim if it was not true.
I am surprized that there is not more reaction about this on the bullboard.
In my opinion, this is very interesting as the department of defense (the US army) as no interest in Ryplazim for congenital deficiancy. IMHO, they must have an interest in wound and burned healing.
If they can heal a soldier or any member of the army faster, it is a strategic tool for them.
A wounded soldier takes much more ressources than a dead soldier. It is a known fact in the army. During a conflict, you better wound the enemy then kill them because of that.
So if the army have a drug that help the healing of their troops, it it a strategic tool.
Anyway, time will tell.